Canada Markets closed

LexaGene Holdings Inc. (LXXGF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.2200-0.0259 (-10.55%)
At close: 02:46PM EST
Full screen
Trade prices are not sourced from all markets
Previous Close0.2459
Open0.2180
BidN/A x N/A
AskN/A x N/A
Day's Range0.2110 - 0.2302
52 Week Range0.2000 - 1.2200
Volume56,869
Avg. Volume224,319
Market Cap26.207M
Beta (5Y Monthly)2.09
PE Ratio (TTM)N/A
EPS (TTM)-0.0940
Earnings DateJun. 28, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire

    LexaGene Starts the Year with Additional MiQLab Sales

    BEVERLY, Mass., Jan. 03, 2022 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, is pleased to announce three additional purchase orders for MiQLab™ Systems from veterinary clinics in Michigan, Minnesota, and New York. Julie Griggs, LexaGene’s Global Director of Sales, stated, “My team is diligently engaged with numerous veterinary practices, both priva

  • GlobeNewswire

    LexaGene Announces Results of Annual General and Special Meeting

    BEVERLY, Mass., Dec. 17, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that has commercialized an instrument for automated multiplex PCR testing, is pleased to announce the voting results of the Company’s 2021 Annual General Special Meeting (the “Meeting”) held on December 16, 2021 in Vancouver, British Columbia. A total of 50,094,097 common shares were voted at the Meeting, representing 41.97% of the votes attached

  • GlobeNewswire

    LexaGene Closes Multiple MiQLab Sales

    BEVERLY, Mass., Dec. 03, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen detection systems, is pleased to announce two purchase orders from Kuma Veterinary Clinic and the Emergency Veterinary Services of Roanoke. Dr. Jack Regan, LexaGene’s Founder and CEO commented, “I’m pleased to announce that we have closed additional MiQLab System sales to private hospitals. Veterinarian